Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:IRWD   3:59:57 PM EDT
13.50
+0.05 (+0.37%)
5:13:56 PM EDT: $13.50 0.00 (0.00%)
Products

Ironwood Pharmaceuticals Reports FDA Approval Of Revised Linzess Label

Published: 08/26/2021 11:18 GMT
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A (IRWD) - Ironwood Pharmaceuticals Announces FDA Approval of Revised Linzess® (linaclotide) Label.
Ironwood Pharmaceuticals - Updated Linzess Label Modifies Boxed Warning for Risk of Serious Dehydration and Contraindication Against Use in Children to Those Less Than Two Years of Age.
Ironwood Pharmaceuticals Inc - Boxed Warning and Contraindication Previously Applied to All Children Less Than 18 Years of Age and Less Than 6 Years of Age, Respectively.
Ironwood Pharmaceuticals Inc - Safety and Effectiveness of Linzess in Patients Less Than 18 Years of Age Have Not Been Established.